News & partners

Dianosic is a biotech focused on the development of novel solutions integrated drug and
delivery system for the localized treatment of patients with chronic rhinitis and chronic rhinosinusitis.

Latest news

All Awards Company Events Invest Partners

Nov 03, 2025

Dianosic raises €7M !

Oct 10, 2024

Dianosic X WiSEED: Fundraising

Feb 12, 2024

Dianosic shortlisted for the “Trophées des Entreprises Alsace 2024” award

Feb 12, 2024

Dianosic x France Deeptech

Sep 08, 2023

Dianosic plans to raise EUR 10m in Series A; to seek exit sale around 2026

Jul 10, 2023

Major Funding Milestone: Dianosic raises 4.7M€ – February 2023

1
2
3
4
5

They support us

Our investors

We built a solid network of partners to support company funding and growth.

Wiseed

Bpi France

Fondation Force

Eurométropole de Strasbourg

Banque Populaire Rives de Paris

Caisse d’épargne Grand Est

La Région Grand Est

Let's connect

Need more information?

Contact

DIANOSIC

Biotech · Paris & Strasbourg · Founded 2017

Reinventing drug delivery via the intranasal route

Dianosic develops complex intranasal formulations and advanced drug-delivery solutions for chronic respiratory diseases and central nervous system disorders.

Key highlights

01

Cutting-edge platform of intranasal, long-acting solid dosage forms

The DIAXX insert delivers a targeted, low dose of drug in a controlled manner for up to 12 months.

02

Significant potential across respiratory and neurological indications

Chronic allergic rhinitis (8M), chronic rhinosinusitis (5M) and CNS diseases via Nose-to-Brain delivery (Schizophrenia, Parkinson — 23M) represent large adressable markets.

03

Solving a critical adherence challenge

50% of patients do not adhere to their medications across therapeutic areas. Our "insert and forget" approach guarantees 100% adherence.

04

€7M raised in 2025 — led by Aptar Pharma

Series A round with Aptar (Global drug delivery leader), Noshaq, Capital Grand Est and Finovam Gestion to accelerate clinical development.

05

A complementary team

In-house Pharma and Medtech expertise supported by a Scientific Board composed of world-renowned experts.

© 2026 Dianosic SAS

contact@dianosic.com